Benefit of Portrazza on NSCLC Found to Be Minor and Limited to Metastatic Squamous Forms
Lung Cancer, News
An early benefit assessment indicated that while Portrazza (necitumumab) increases overall patient survival, additional negative effects reduce the impact of this outcome and result in only a minor added benefit for ... Read more